HGEN HGEN

Humanigen Stock Price

0.345
-0.0012 (-0.35%)
0.345
Volume 5,405,826
Bid Price 0.342
Ask Price 0.345
News -
Day High 0.3499

Low
0.334

52 Week Range

High
18.22

Day Low 0.334
Company Name Stock Ticker Symbol Market Type
Humanigen Inc HGEN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.0012 -0.35% 0.345 18:58:47
Open Price Low Price High Price Close Price Prev Close
0.3499 0.334 0.3499 0.3403 0.3462
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
10,861 5,405,826 $ 0.3402002 $ 1,839,063 - 0.334 - 18.22
Last Trade Time Type Quantity Stock Price Currency
18:58:47 formt 200 $ 0.345 USD

Period:

Draw Mode:

Humanigen Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 35.76M 103.66M 92.30M $ 3.60M $ - -4.05 -0.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 4.32M 0.80%

more financials information »

Humanigen News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HGEN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.36010.38680.3340.36445428,206,085-0.0151-4.19%
1 Month0.460.46750.3340.389695412,166,601-0.115-25.0%
3 Months2.023.250.3340.71437278,906,664-1.68-82.92%
6 Months1.884.1050.3341.044,926,435-1.54-81.65%
1 Year15.7918.220.3342.623,532,768-15.45-97.82%
3 Years10.8529.200.3346.932,568,142-10.51-96.82%
5 Years10.8529.200.3346.932,568,142-10.51-96.82%

Humanigen Description

Humanigen Inc is a biopharmaceutical company engaged in the development of proprietary monoclonal antibodies for various oncology indications and to enhance T-cell therapies, making these treatments safer and cost-effective. It focuses on preventing the serious and potentially life-threatening side-effects associated with chimeric antigen receptor T-cell (CAR-T) therapy. Its pipeline includes programs such as Lenzilumab, Ifabotuzumab, and HGen005.


Your Recent History
NASDAQ
HGEN
Humanigen
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now